Literature DB >> 11056388

Molecular cloning, expression, and chromosomal mapping of human chondroitin 4-sulfotransferase, whose expression pattern in human tissues is different from that of chondroitin 6-sulfotransferase.

T Okuda1, S Mita, S Yamauchi, T Matsubara, F Yagi, D Yamamori, M Fukuta, A Kuroiwa, Y Matsuda, O Habuchi.   

Abstract

Chondroitin 4-sulfotransferase (C4ST) catalyzes the transfer of sulfate from 3'-phosphoadenosine 5'-phosphosulfate to position 4 of the N-acetylgalactosamine residues of chondroitin. We previously reported the cloning of C4ST cDNA from mouse brain. We here report the cloning and expression of human C4ST cDNA. The cDNA was isolated from a human fetal brain cDNA library by hybridization with a DNA probe prepared from rat poly(A)(+) RNA used for the cloning of mouse C4ST cDNA. The cDNA comprises a single open reading frame that predicts a Type II transmembrane protein composed of 352 amino acids. The protein has an amino acid sequence homology of 96% with mouse C4ST. When the cDNA was introduced into a eukaryotic expression vector and transfected in COS-7 cells, the sulfotransferase activity that transfers sulfate to both chondroitin and desulfated dermatan sulfate was overexpressed. Northern blot analysis indicated that human C4ST mRNAs (6.0 and 1.9 kb) are expressed ubiquitously in various adult human tissues. Dot blot analysis has shown that human C4ST is strongly expressed in colorectal adenocarcinoma and peripheral blood leukocytes, whereas strong expression of human chondroitin 6-sulfotransferase (C6ST) is observed in aorta and testis. These observations suggest that the expression of C4ST and C6ST may be controlled differently in human tissues. The C4ST gene was localized to chromosome 12q23.2-q23.3 by fluorescence in situ hybridization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11056388     DOI: 10.1093/oxfordjournals.jbchem.a022813

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  7 in total

1.  N-linked oligosaccharides are required to produce and stabilize the active form of chondroitin 4-sulphotransferase-1.

Authors:  Akiko Yusa; Ken Kitajima; Osami Habuchi
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

2.  Chondroitin 4-sulphotransferase-1 and chondroitin 6-sulphotransferase-1 are affected differently by uronic acid residues neighbouring the acceptor GalNAc residues.

Authors:  Takayoshi Yamada; Shiori Ohtake; Makoto Sato; Osami Habuchi
Journal:  Biochem J       Date:  2004-12-15       Impact factor: 3.857

3.  CHST11/13 Regulate the Metastasis and Chemosensitivity of Human Hepatocellular Carcinoma Cells Via Mitogen-Activated Protein Kinase Pathway.

Authors:  Huimin Zhou; Yanping Li; Xiaobo Song; Yongfu Zhao; Lei Cheng; Lifen Zhao; Li Jia
Journal:  Dig Dis Sci       Date:  2016-03-18       Impact factor: 3.199

4.  Construction of a chondroitin sulfate library with defined structures and analysis of molecular interactions.

Authors:  Nobuo Sugiura; Tatsumasa Shioiri; Mie Chiba; Takashi Sato; Hisashi Narimatsu; Koji Kimata; Hideto Watanabe
Journal:  J Biol Chem       Date:  2012-11-05       Impact factor: 5.157

Review 5.  Insights from human genetic studies into the pathways involved in osteoarthritis.

Authors:  Louise N Reynard; John Loughlin
Journal:  Nat Rev Rheumatol       Date:  2013-08-20       Impact factor: 20.543

6.  Abnormal developmental control of replication-timing domains in pediatric acute lymphoblastic leukemia.

Authors:  Tyrone Ryba; Dana Battaglia; Bill H Chang; James W Shirley; Quinton Buckley; Benjamin D Pope; Meenakshi Devidas; Brian J Druker; David M Gilbert
Journal:  Genome Res       Date:  2012-05-24       Impact factor: 9.043

7.  The chondroitin/dermatan sulfate synthesizing and modifying enzymes in laryngeal cancer: expressional and epigenetic studies.

Authors:  Dimitrios Kalathas; Irene-Eva Triantaphyllidou; Nicholas S Mastronikolis; Panos D Goumas; Thoedore A Papadas; Gabriel Tsiropoulos; Demitrios H Vynios
Journal:  Head Neck Oncol       Date:  2010-10-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.